James M. Thorburn, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 26,900 shares at $51.29 ($1.3M) on 2022-08-16, disclosed to the SEC on 2022-08-18.
Seasonal sale ($1.3M) by Chief Financial Officer — this insider has traded TWST in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.97 | 900 | $45K | 3.4% |
| 2 | $51.29 | 2,418 | $124K | 9.3% |
| 3 | $51.29 | 2,418 | $124K | 9.3% |
| 4 | $51.82 | 1,582 | $82K | 6.2% |
| 5 | $51.82 | 1,582 | $82K | 6.2% |
| 6 | $48.32 | 6,093 |
| $294K |
| 22.1% |
| 7 | $48.32 | 6,093 | $294K | 22.1% |
| 8 | $48.92 | 2,907 | $142K | 10.7% |
| 9 | $48.92 | 2,907 | $142K | 10.7% |
| Total | $49.45 avg | 26,900 | $1.3M | 100% |
| Filing → |
| TWST | SELL | 2022-03-07 | $359K | — | Filing → |
| TWST | SELL | 2022-02-23 | $432K | — | Filing → |
| TWST | SELL | 2021-12-10 | $1.1M | — | Filing → |